4-Fluorophenylacetone, 99%
4-Fluorophenylacetone, 99%
4-Fluorophenylacetone, 99%
4-Fluorophenylacetone, 99%
Thermo Scientific Chemicals

4-Fluorophenylacetone, 99%

CAS: 459-03-0 | C9H9FO | 152.17 g/mol
Have Questions?
Change viewbuttonViewtableView
Quantity:
1 g
5 g
Catalog number L11720.03
also known as L11720-03
Price (EUR)
31,20
Each
Add to cart
Quantity:
1 g
Request bulk or custom format
Price (EUR)
31,20
Each
Add to cart
Chemical Identifiers
CAS459-03-0
IUPAC Name1-(4-fluorophenyl)propan-2-one
Molecular FormulaC9H9FO
InChI KeyZUEKIIWSVFBTCM-UHFFFAOYSA-N
SMILESCC(=O)CC1=CC=C(F)C=C1
View more
SpecificationsSpecification SheetSpecification Sheet
FormLiquid
Appearance (Color)Clear colorless to yellow
Assay (GC)≥98.5%
Refractive Index1.4945-1.4975 @ 20?C
4-Fluorophenylacetone is an important raw material and intermediate used in organic synthesis, pharmaceuticals, agrochemicals and dyestuff fields.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
4-Fluorophenylacetone is an important raw material and intermediate used in organic synthesis, pharmaceuticals, agrochemicals and dyestuff fields.

Solubility
Not miscible or difficult to mix with water.

Notes
Keep container tightly sealed. Store in cool, dry conditions in well sealed containers. Incompatible with oxidizing agents.
RUO – Research Use Only

General References:

  1. Amgad G. Habeeb.; P. N. Praveen Rao.; Edward E. Knaus. Design and Synthesis of 4,5-Diphenyl-4-isoxazolines: Novel Inhibitors of Cyclooxygenase-2 with Analgesic and Antiinflammatory Activity. J. Med. Chem. 2001, 44 (18), 2921-2927.
  2. Tyson Chasse.; Robert Wenslow.; Yuri Bereznitski. Chromatographic selectivity study of 4-fluorophenylacetic acid positional isomers separation. Journal of Chromatography A. 2007, 1156 (1-2), 25-34.